Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARN-75039 for Lassa Fever in West Africa
NCT07419373Phase 2Suspended
- Start
- Feb 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ARN-75039 in Lassa fever. Started Feb 2026; status: suspended.
02
Drugs
ARN-75039
03
Conditions
Lassa fever
Beyond the preview
Go deeper on NCT07419373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07419373.